Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study (LIS)

April 13, 2016 updated by: Anne Kristin M. Fell, Sykehuset Telemark

Circulating Inflammatory Markers, Exhaled NO and Lung Function in Cement Production Workers; a Cross-shifts Study

The aim of the study is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).

Study Overview

Status

Completed

Conditions

Detailed Description

OBJECTIVE:

Cement dust is suspected to be one of the main factors causing increased mortality among workers not only in the cement production industry, but also in the construction industry worldwide. Our aim is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).

METHODS:

All employees from Norwegian cement plants, are invited to participate. The workers will perform spirometry, single-breath determination of carbon monoxide uptake, blood samples before and after a working shift of 6-8 hours, and again after 24 hours. Information on respiratory symptoms, allergy and former respiratory disease as well as exposure information will be given on a self-reported questionnaire. Changes in lung function indices, nitric oxide levels and serum inflammatory markers will be calculated. Nitric oxide will only be measured in non-smokers. We will compare cement dust exposed workers with low-level or non-exposed workers (controls).

Study Type

Observational

Enrollment (Actual)

95

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Skien, Norway, N-3710
        • Sykehuset Telemark HF

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All employees of two Norwegian cement production plants are invited to participate.

Description

Inclusion Criteria:

  • Employees from a Norwegian cement production plant

Exclusion Criteria:

  • Exhaled nitric oxide measurements: smokers
  • Substantial previous work in quarry or as a miner

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Lung Function Measurements During One Work Shift (6-8h)
Time Frame: baseline and 6-8h
Changes in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity
baseline and 6-8h

Secondary Outcome Measures

Outcome Measure
Time Frame
Changes in FeNO Measurements During One Shift (6-8h)
Time Frame: baseline and 6-8h
baseline and 6-8h
Changes in Serum/Plasma Inflammatory Markers During One Shift (6-8h)
Time Frame: Baseline and 6-8h
Baseline and 6-8h
Changes in FeNO Measurements Between Baseline (0h) and 32 h
Time Frame: 0-32h
0-32h
Changes in Serum/Plasma Inflammatory Markers Between Baseline and 32 h
Time Frame: 0-32h
0-32h

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Johny Kongerud, MD, PhD, Rikshospitalet University Hospital
  • Study Chair: Helge Kjuus, MD, PhD, National Institute of occupational Health, NIOH
  • Principal Investigator: Marit Skogstad, MD, PhD, National Institute of occupational Health, NIOH

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Primary Completion (Actual)

January 1, 2009

Study Completion (Actual)

January 1, 2009

Study Registration Dates

First Submitted

July 30, 2008

First Submitted That Met QC Criteria

August 1, 2008

First Posted (Estimate)

August 4, 2008

Study Record Updates

Last Update Posted (Estimate)

May 20, 2016

Last Update Submitted That Met QC Criteria

April 13, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The individual data is no longer available, due to regulations in Norway requiering individual data to be deleted 5 years after the study was compleeted.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Obstruction

3
Subscribe